Bank of Nova Scotia
PROK icon

Bank of Nova Scotia’s ProKidney PROK Stock Holding History

Bank of Nova Scotia’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-40,000
Closed -$398K – 1214
2022
Q2 		$398K Hold
40,000
– – ﹤0.01% 1042
2022
Q1 		$396K Hold
40,000
– – ﹤0.01% 1073
2021
Q4 		$396K Buy
+40,000
New +$395K ﹤0.01% 1115

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Bank of Nova Scotia's PROK Position: Q3 2022 in Review

Bank of Nova Scotia sold out of ProKidney (PROK) in Q3 2022, closing a stake of 40,000 shares — an estimated $398K sold.

Bank of Nova Scotia first reported a position in PROK in Q4 2021 and held it in 3 quarters. The position peaked at $398K in Q2 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • Bank of Nova Scotia reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • Bank of Nova Scotia sold 40,000 ProKidney shares in Q3 2022, an estimated $398K.
  • Bank of Nova Scotia first reported a position in ProKidney in Q4 2021 and held it in 3 quarters.
  • Bank of Nova Scotia's ProKidney position peaked at $398K in Q2 2022.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Bank of Nova Scotia's 13F filing for Q3 2022, filed 10 Nov 2022.